BAY1895344, a novel ataxia telangiectasia and RAD3-related (ATR) inhibitor, is active in vivo against ATRX mutated uterine leiomyosarcoma (212)

Autor:	Justin Harold, Diego Manavella, Stefania Bellone, Eric Siegel, Dennis Mauricio, Tobias Hartwich, Luca Arrigo Zammataro, Levent Mutlu, Abdelrahman AlAshqar, Gary Altwerger, Gulden Menderes, Elena Ratner, Gloria Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter Schwartz, Ludmil Alexandrov, Alessandro Santin
Rok vydání:	2022
Předmět:	Oncology Obstetrics and Gynecology
Zdroj:	Gynecologic Oncology. 166:S118
ISSN:	0090-8258
DOI:	10.1016/s0090-8258(22)01437-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c021de40868d7ceb25c9c727e74ced46 https://doi.org/10.1016/s0090-8258(22)01437-8 Zobrazit plný text záznamu Full Text from ScienceDirect